Amneal Pharmaceuticals's total assets for Q1 2026 were $3.54B, a decrease of -3.75% from the previous quarter. AMRX total liabilities were $3.50B for the fiscal quarter, a -4.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.